Table 3

The outcome indicatorsa, b

Variables

Clinical pathway, n = 238

No intervention, n = 238

Between-group difference, OR (95% CI)

P-valuec


In-hospital death rate within 30 days of admission to hospital

18/238 (7.6) (4.5 to 11.7)

25/238 (10.5) (6.9 to 15.1)

0.70 (0.35 to 1.37)

0.34

In-hospital death rate within 7 days of admission to hospital

7/238 (2.9) (1.2 to 6.0)

16/238 (6.7) (3.6 to 10.2)

0.42 (0.15 to 1.11)

0.05

In-hospital death rate within 30 days of stroke attack

18/238 (7.6) (4.5 to 11.7)

25/238 (10.5) (6.9 to 15.1)

0.70 (0.35 to 1.37)

0.34

Post-discharge death rates (1, 3, 6, 12 months after discharge)

3/53 (5.7) (1.2 to 15.7)

0/27 (0.0) (0.0 to 12.8)

1.54 (1.31 to 1.81)

0.55

In-patients length of stay, n (mean ± SD)

229 (11.78 ± 6.6)

219 (10.88 ± 7.9)

-

0.19

Within 9 days of length of stay in hospital patients' rate

94/227 (41.4) (34.9 to 48.1)

114/215 (53.0) (46.1 to 59.8)

1.60 (1.08 to 2.37)

0.02

Pressure-sore incidence rate

4/229 (1.7) (0.5 to 4.4)

12/219 (5.5) (2.9 to 9.4)

0.31 (0.08 to 0.94)

0.04

Overall in-hospital complications rate

53/229 (23.1) (17.8 to 29.2)

67/219 (30.6) (24.6 to 37.2)

0.68 (0.44 to 1.06)

0.09

Overall post-discharge complications rate

12/103 (11.7) (6.2 to 19.5)

0/27 (0.0) (0.0 to 12.8)

1.30 (0.98 to 1.43)

0.07

Institutionalization at discharge

26/92 (28.3) (19.4 to 38.6)

15/64 (23.4) (14.0 to 36.2)

1.29 (0.58 to 2.87)

0.58

In-hospital re-admission rate (within 30 days of discharge)

0/211 (0.0) (NC)

0/194 (0.0) (NC)

NC

NC

Return to pre-stroke functioning in daily life rate (with ADL/case mix adjustment)

97/208 (46.6) (39.1 to 52.9)

22/90 (24.4) (16.0 to 34.6)

2.70 (1.50 to 4.88)

< 0.001

Return to pre-stroke functioning in daily life rate at follow-up at 3 months (with ADL/case mix adjustment)

62/101 (61.4) (51.2 to 70.9)

5/9 (55.5) (21.2 to 86.3)

1.27 (0.27 to 5.92)

0.73


ADL, Activities of daily living; NC, Not calculable

aBecause of missing data denominators used to calculate percentages may differ from group totals (clinical pathway versus no intervention).

bValues are n/total n (%) (95% CI) unless otherwise indicated.

cP-values represent comparison of each characteristic between two groups (clinical pathway versus no intervention), and all P-values are two-sided.

Panella et al. BMC Medicine 2012 10:71   doi:10.1186/1741-7015-10-71

Open Data